Literature DB >> 19456149

Novel bispidine ligands and their first-row transition metal complexes: trigonal bipyramidal and trigonal prismatic geometries.

Peter Comba1, Christina Haaf, Hubert Wadepohl.   

Abstract

Four very rigid second generation bispidine-based ligands (bispidine = 3,7-diazabicyclo[3.3.1]nonane; tetra-, penta- and hexadentate; exclusively tertiary amine donors except for one of the pentadentate ligands, where one of the donors is a pyridyl group) and their Co(II), Ni(II), Cu(II), and Zn(II) complexes are reported. The experimentally determined X-ray crystal structures and computational data, based on empirical force field (MM) and approximate density functional theory (DFT) calculations, indicate that these new ligands, which are based on a modular system and therefore allow for a wide range of donor sets and coordination geometries, have rather large cavities (i.e., lead to a preference for +II over +III oxidation states and induce relatively low ligand fields), enforce trigonal geometries (pentacoordinate systems: preference for trigonal bipyramidal, hexacoordinate complexes: preference for trigonal prismatic), and lead, especially for Cu(II), to very high complex stabilities.

Entities:  

Year:  2009        PMID: 19456149     DOI: 10.1021/ic900571v

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  Tri-tert-butyl 3-oxo-4-oxa-1,8,11-triazaspiro[5.6]dodecane-1,8,11-triacetate.

Authors:  Raghvendra Singh Sengar; Steven J Geib; Archana Nigam; Erik C Wiener
Journal:  Acta Crystallogr C       Date:  2010-03-06       Impact factor: 1.172

2.  Dioxygen reactivity of new bispidine-copper complexes.

Authors:  Peter Comba; Christina Haaf; Stefan Helmle; Kenneth D Karlin; Shanthi Pandian; Arkadius Waleska
Journal:  Inorg Chem       Date:  2012-02-14       Impact factor: 5.165

3.  Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics.

Authors:  Ian Moore F Gilpin; Martin Ullrich; Thomas Wünsche; Kristof Zarschler; Ondřej Lebeda; Jens Pietzsch; Hans-Jürgen Pietzsch; Martin Walther
Journal:  ChemMedChem       Date:  2021-06-16       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.